CircMYOF acts as a miR-4739 sponge to promote progression and facilitate glycolysis via VEGFA/PI3K/AKT pathway in pancreatic ductal adenocarcinoma.

被引：0
|
作者：
Zheng, Dandan [1 ]
Huang, Xianxian [2 ]
Peng, Juanfei [1 ]
Zhuang, Yanyan [1 ]
Li, Yuanhua [3 ]
Qu, Junchi [1 ]
Zhang, Shineng [1 ]
Huang, Fengting [1 ]
机构：
[1] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 8, Shenzhen, Peoples R China
[3] Sun Yat Sen Univ, Tungwah Hosp, Dongguan, Peoples R China
来源：
CANCER RESEARCH | 2021年 / 81卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-026
引用
收藏
页码：20 / 20
页数：1
相关论文
共 50 条
  • [11] SERPINA1 promotes the invasion, metastasis, and proliferation of pancreatic ductal adenocarcinoma via the PI3K/Akt/NF-κB pathway
    Xiubing, Chen
    Huazhen, Li
    Xueyan, Wei
    Jing, Ning
    Qing, Li
    Haixing, Jiang
    Shanyu, Qin
    Jiefu, Lu
    BIOCHEMICAL PHARMACOLOGY, 2024, 230
  • [12] circPUM1 Activates the PI3K/AKT Signaling Pathway by Sponging to Promote the Proliferation, Invasion and Glycolysis of Pancreatic Cancer
    Chen, Yang
    Liu, Yuhong
    Tao, Qiang
    Fan, YouWen
    Ma, Chao
    Li, Dong
    Huang, Fei
    Tang, Di
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2022, 23 (11) : 1405 - 1414
  • [13] Activation of the PI3K/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib
    Ge, Weiyu
    Wang, Yanling
    Quan, Ming
    Mao, Tiebo
    Bischof, Evelyne Y.
    Xu, Haiyan
    Zhang, Xiaofei
    Li, Shumin
    Yue, Ming
    Ma, Jingyu
    Yang, Haiyan
    Wang, Lei
    Yu, Zhengyuan
    Wang, Liwei
    Cui, Jiujie
    MOLECULAR CANCER, 2024, 23 (01)
  • [14] Activation of the PI3K/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib
    Weiyu Ge
    Yanling Wang
    Ming Quan
    Tiebo Mao
    Evelyne Y. Bischof
    Haiyan Xu
    Xiaofei Zhang
    Shumin Li
    Ming Yue
    Jingyu Ma
    Haiyan Yang
    Lei Wang
    Zhengyuan Yu
    Liwei Wang
    Jiujie Cui
    Molecular Cancer, 23
  • [15] Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway
    Huang, Lu
    Yang, Qiong
    Chen, Huihong
    Wang, Zhenggeng
    Liu, Qi
    Ai, Shuhua
    OPEN MEDICINE, 2022, 17 (01): : 626 - 637
  • [16] LncRNA TP73-AS1 promoted the progression of lung adenocarcinoma via PI3K/AKT pathway
    Liu, Chunfeng
    Ren, Lei
    Deng, Jun
    Wang, Songping
    BIOSCIENCE REPORTS, 2019, 39
  • [17] Glycoprotein M6A Suppresses Lung Adenocarcinoma Progression via Inhibition of the PI3K/AKT Pathway
    Zhang, Qian
    Deng, Shuangshuang
    Li, Qinchuan
    Wang, Guangxue
    Guo, Zhongliang
    Zhu, Dongyi
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [18] miR-494 promotes progression of retinoblastoma via PTEN through PI3K/AKT signaling pathway
    Xu, Fen
    Liu, Guiqin
    Wang, Lijuan
    Wang, Xiyan
    Jin, Xiao
    Bo, Wen
    ONCOLOGY LETTERS, 2020, 20 (02) : 1952 - 1960
  • [19] MBNL3 Acts as a Target of miR-302e to Facilitate Cell Proliferation, Invasion and Angiogenesis of Gastric Adenocarcinoma via AKT/VEGFA Pathway
    Tang, Weiping
    Huang, Can
    Jiang, Bing
    Lin, Junjun
    Lu, Yecai
    JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2024, 34 (07) : 1433 - 1442
  • [20] MiR-21 inhibitor suppressed the progression of retinoblastoma via the modulation of PTEN/PI3K/AKT pathway
    Gui, Fu
    Hong, Zhengdong
    You, Zhipeng
    Wu, Hongxi
    Zhang, Yulan
    CELL BIOLOGY INTERNATIONAL, 2016, 40 (12) : 1294 - 1302
12345